Back to Atlas
APotentially durableStandard research/education caution
CMP-0049
Supplement/research
Fisetin
Senolytic / Flavonoid
Potential senescent-cell reduction and anti-inflammatory longevity positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Flavonoid
- Primary mechanism
- PI3K/AKT/NF-κB and senescent-cell survival pathway modulation
- Primary market use
- Longevity / senolytics
Pharmacology
- Molecular weight (Da)
- 286.24
- Oral bioavailability
- Oral; low/variable
- Half-life
- Not well established; likely short
- Route tags
- Route-dependent / verify
- Evidence level
- Preclinical/Human trials
- Clinical status
- Supplement/research
- Value-for-money score
- 7 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Higher practical value than toxic senolytics due supplement availability, but human efficacy remains uncertain